syndrome (RDS), cerebral palsy and neonatal death upon steroid administration. All probabilities and utilities were derived from the literature. Neonatal outcomes included IUFD, RDS, cerebral palsy, and neonatal death. Maternal outcomes included maternal death and rates of severe hemorrhage defined as bleeding requiring greater than 10 units of blood products. RESULTS: In a theoretical cohort of 10,000 women with placenta accreta, scheduled cesarean hysterectomy at 35 weeks of gestation with corticosteroid administration optimized maternal and neonatal outcomes (table) . Delivery at 32 weeks resulted in the fewest maternal deaths (298) and incidents of severe hemorrhage (194). Neonatal outcomes except for IUFD were optimized with delivery at 37 weeks of gestation and included 23 cases of neonatal death, 55 cases of cerebral palsy, and 482 cases of RDS. CONCLUSION: Based on our analysis, optimal management for placenta accreta spectrum is a scheduled cesarean hysterectomy at 35 weeks gestation in a multidisciplinary care center with prior corticosteroid administration. Further efforts to identify those patients at risk of requiring an emergent delivery would help to further optimize maternal and neonatal outcomes. OBJECTIVE: To validate the accuracy of an external device which monitors uterine electrical activity by comparing it to tocodynamometry among obese patients. STUDY DESIGN: This was a prospective observational study of laboring women at Montefiore Medical Center from February 2017 to April 2018. Inclusion criteria: maternal age >18 years old, singleton pregnancy, gestational age > 24 weeks and BMI >/¼ 30 kg/m2. Exclusion criteria: allergy to silver, implanted electronic device of any kind and irritated skin or open wound on the abdominal wall. Patients were monitored simultaneously with the EUM device, EUM300 (OB Tools, Migdal HaEmek, Israel), and by TOCO for at least 30 minutes. Two blinded obstetricians reviewed the tracings. The primary outcome of the study was continuous, interpretable tracing and secondary outcomes were total number of contractions, timing of onset of contractions and duration of contractions. Based on McNemar's test to compare proportion of discontinuity between the two methods, enrolling 55 patients provided 80% study power to detect an odds ratio of 3.2 with a two-sided type I error rate of 5%. RESULTS: A total of 65 obese patients were monitored via simultaneous EUM and TOCO devices. The average gestational age was 39.0 weeks with 43 (66.15%) patients in latent labor. 35 (53.85%) patients were receiving oxytocin at the time of the recordings and 45 ajog.org
OBJECTIVE: To validate the accuracy of an external device which monitors uterine electrical activity by comparing it to tocodynamometry among obese patients. STUDY DESIGN: This was a prospective observational study of laboring women at Montefiore Medical Center from February 2017 to April 2018. Inclusion criteria: maternal age >18 years old, singleton pregnancy, gestational age > 24 weeks and BMI >/¼ 30 kg/m2. Exclusion criteria: allergy to silver, implanted electronic device of any kind and irritated skin or open wound on the abdominal wall. Patients were monitored simultaneously with the EUM device, EUM300 (OB Tools, Migdal HaEmek, Israel), and by TOCO for at least 30 minutes. Two blinded obstetricians reviewed the tracings. The primary outcome of the study was continuous, interpretable tracing and secondary outcomes were total number of contractions, timing of onset of contractions and duration of contractions. Based on McNemar's test to compare proportion of discontinuity between the two methods, enrolling 55 patients provided 80% study power to detect an odds ratio of 3.2 with a two-sided type I error rate of 5%. RESULTS: A total of 65 obese patients were monitored via simultaneous EUM and TOCO devices. The average gestational age was 39.0 weeks with 43 (66.15%) patients in latent labor. 35 (53.85%) patients were receiving oxytocin at the time of the recordings and 45 (69.3%) patients had epidural. On average, the EUM was 1.49 minutes (CI¼ 0.62, 2.37) more interpretable/continuous in a 30 min tracing (p¼0.001). Overall, EUM detected 39% (CI¼ 23%, 57%) more contractions in a 30 min tracing compared to TOCO (p<0.0001). With regards to patient preference, 42 (64.62%) patients undergoing simultaneous monitoring preferred the EUM device over the TOCO. CONCLUSION: Given the challenges of using a tocodynomameter with obese women, consideration should be given to replacing it with the EUM device, which appears to be more sensitive and accurate and preferred by patients.
372 Placental edge to internal os distance and mode of delivery in low-lying placentas OBJECTIVE: Transvaginal ultrasound (TVU) is the technique of choice for evaluation of placenta previa. Low-lying placenta is diagnosed when the placental edge to internal os (PI) distance is 1-20 mm. Due to paucity of data, mode of delivery in low-lying placentas with PI distance of 11-20 mm is still controversial. In a retrospective analysis, we reported a 69% rate of successful vaginal delivery (VD) in these patients. However, a recent Clinical Expert Series report from the ACOG concluded that the optimal management of patients with PI distance of 11-20 mm is uncertain and should be individualized. Here we prospectively investigate the mode of delivery in patients with a low-lying placenta and the likelihood of VD according to PI distance. STUDY DESIGN: Patients with low-lying placenta confirmed at TVU 32 0/7 weeks in 2009-2018 were prospectively recorded in a dedicated log book. Pre-labor cesarean section (CS) was proposed to patients with PI distance of 1-10 mm (group 1), whereas cases with PI distance of 11-20 mm (group 2) were counseled in favor of VD, unless contraindicated. Excluded from the analyses were cases with suspected accretion, last TVU >28 days before delivery, and PI distance >20 mm during follow up monitoring. Statistical analyses were conducted with SPSS software with significance set at p<0.05. RESULTS: During the study period, 102 cases of low-lying placenta were identified. Eight cases were excluded because of suspected accretion (n¼5) or last TVU-delivery interval >28 days (n¼3). PI distance became >20 mm in 24 patients. Analyses were performed in 70 cases: 18 belonged to group 1 and 52 to group 2. Table shows maternal, ultrasound, and delivery data of the two groups. VD occurred in 71.2% cases in group 2 versus 11.1% cases in group 1. Four patients attempted VD in group 1, and 1 required urgent CS for bleeding. In group 2, 9 women underwent pre-labor CS, 2 of whom for refusal of trial of VD, whereas urgent CS for bleeding occurred in 2 patients allowed to labor. No difference in blood loss at delivery was identified between the two groups. CONCLUSION: To the best of our knowledge, this is the largest prospective study on mode of delivery in low-lying placentas. Our results show that most women with a PI distance of 11-20 mm can deliver vaginally if allowed to labor, with no increased risk of hemorrhage. In the context of a worldwide policy attempting to reduce CS rates, we hope our data can provide sufficient evidence to promote VD in patients with placental edge >10 mm from the internal os.
